Douglas Dolnak
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
- Ophthalmology top 2%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
- Retinal and Optic Conditions
Papers in
-
- Inflammatory mediators and NSAID effects 2
-
- Neuropeptides and Animal Physiology 2
- Co-authors
- Mark Hyman Rapaport (4 shared papers)Barbara L. Brody (1 shared paper)Anthony Gamst (1 shared paper)Amanda R. Smith (1 shared paper)Rebecca Williams (1 shared paper)Robert M. Kaplan (1 shared paper)Stuart I. Brown (1 shared paper)Rachel Maddux (2 shared papers)
- Journals
- Biological Psychiatry (2 papers)Ophthalmology (1 paper)The International Journal of Neuropsychopharmacology (1 paper)PubMed (2 papers)
- Partner nations
- United States
In The Last Decade
Douglas Dolnak
6 papers receiving 614 citations
Peers
Comparison fields: 5 of 89
- Biological Psychiatry 108
- Ophthalmology 300
- Behavioral Neuroscience 51
- Epidemiology 271
- Radiology, Nuclear Medicine and Imaging 170
Countries citing papers authored by Douglas Dolnak
This map shows the geographic impact of Douglas Dolnak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Dolnak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Dolnak more than expected).
Fields of papers citing papers by Douglas Dolnak
This network shows the impact of papers produced by Douglas Dolnak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Dolnak. The network helps show where Douglas Dolnak may publish in the future.
Co-authors
The 16 scholars most cited alongside Douglas Dolnak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 452 | |
| 2 | 2005 | 104 | |
| 3 | Lack of retinal toxicity of the anticytomegalovirus drug (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine. | 1992 | 28 |
| 4 | 2003 | 23 | |
| 5 | 2005 | 16 | |
| 6 | Treating patients for comorbid depression, anxiety disorders, and somatic illnesses. | 2006 | 15 |
About Douglas Dolnak
Douglas Dolnak is a scholar working on Pharmacology, Cellular and Molecular Neuroscience, Epidemiology, Molecular Biology and Health, having authored 6 papers that have together received 638 indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (2 papers), Inflammatory mediators and NSAID effects (2 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (1 paper), Cytomegalovirus and herpesvirus research (1 paper), Neonatal Health and Biochemistry (1 paper), Tryptophan and brain disorders (1 paper), Health disparities and outcomes (1 paper) and Ophthalmology and Visual Impairment Studies (1 paper). The work is most often cited by research in Biological Psychiatry (108 citations), Ophthalmology (300 citations), Behavioral Neuroscience (51 citations), Epidemiology (271 citations) and Radiology, Nuclear Medicine and Imaging (170 citations). Douglas Dolnak has collaborated with scholars based in United States. Frequent co-authors include Mark Hyman Rapaport, Barbara L. Brody, Anthony Gamst, Amanda R. Smith, Rebecca Williams, Robert M. Kaplan, Stuart I. Brown, Rachel Maddux, Catherine Bresee and Wei‐Guo Zhu. Their work appears in journals such as Biological Psychiatry, Ophthalmology, The International Journal of Neuropsychopharmacology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.